Related Experiment Video
Updated: May 26, 2026

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue
Published on: August 17, 2016
Targeted MRI contrast agents for pediatric hepatobiliary disease
Jesse L Courtier1, Emily R Perito, Sue Rhee
1Department of Radiology and Biomedical Imaging, UCSF Benioff Children's Hospital, University of California-San Francisco, 505 Parnassus Ave., San Francisco, CA 94143, USA.
Abstract:
New options are available for the magnetic resonance imaging (MRI) assessment of pediatric hepatobiliary disease. This article describes the potential utility for MRI with contrast agents tailored for hepatobiliary imaging. MRI contrast agents that preferentially target the liver may be helpful in characterizing liver masses and bile duct abnormalities in select children. The imaging approach is noninvasive and relatively rapid to perform. It also provides anatomic and functional information and is a radiation-free alternative to other imaging strategies. This relatively new imaging procedure is placed in the context of more established imaging modalities. The pharmacokinetics, technical considerations, and potential applications of these hepatobiliary-specific contrast agents also are discussed.
More Related Videos
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System IV: CMRI
Magnetic Resonance Imaging
Radiological Investigation I: X-ray and CT
Imaging Studies III: Computed Tomography
Imaging Studies IV: Magnetic Resonance Imaging

